The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Syvac Ery/Parvo



Laboratorios SYVA, S.A.UVPA10495/011/001

Main Information

Trade NameSyvac Ery/Parvo
Active SubstancesPorcine parvovirus, strain PVP-7, Inactivated
Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Dosage FormEmulsion for injection
Licence HolderLaboratorios SYVA, S.A.U
License Holder AddressAvda. Párraco Pablo Díez
49-57 León
24010
Spain
Licence NumberVPA10495/011/001

Group Information

ATC CodeQI09AL01 porcine parvovirus + erysipelothrix
Therapeutic ClassImmunological
SpeciesPigs

Status

License statusAuthorised
Licence Issued07/10/2022
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back